Metlife Inc. buy Barclays PLC
Summary
This prediction is currently active. The BUY prediction by Barclays_PLC currently has a performance of 22.54%. Dividends of €0.99 are taken into consideration when calculating the performance. This prediction currently runs until 17.11.24. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionMetLife Inc. (Symbol: MET) (WKN: 934623) is a globally renowned insurance, annuities, and employee benefits company, founded in 1868, with its headquarters in New York City. As a leading player in the financial services sector, this Fortune 500 company offers a comprehensive range of products and services, including life insurance, dental and vision coverage, accident and health insurance, retirement and savings solutions, and more. Boasting a diverse clientele, MetLife serves individual customers, SMEs, and large-scale corporations across the globe, with a strong focus on enhancing value for its shareholders, policyholders, and clients. With an underlying commitment to innovation and customer-centric strategies, this publicly traded company (NYSA: MET) has established its presence in more than 40 countries, continuing to expand its horizons in the changing dynamics of global demographics and financial security needs.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Metlife Inc. | -0.158% | -0.158% |
iShares Core DAX® | -0.116% | 1.953% |
iShares Nasdaq 100 | -2.733% | -1.273% |
iShares Nikkei 225® | -1.721% | 3.263% |
iShares S&P 500 | -1.527% | 0.194% |
Comments by Barclays_PLC for this prediction
In the thread Metlife Inc. diskutieren